TransEnterix, Inc. to present at the 34th Annual J.P. Morgan Healthcare Conference
30 Diciembre 2015 - 3:15PM
Business Wire
TransEnterix, Inc. (NYSE MKT: TRXC) announced today that Todd M.
Pope, President and Chief Executive Officer, will present at the
J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel
in San Francisco, CA. The presentation is scheduled to take place
at 8:30 am Pacific Time on Thursday, January 14, 2016.
To access the live audio webcast or archived recording, use the
following link http://ir.transenterix.com/events.cfm. The replay
will be available on the company’s website.
About TransEnterix
TransEnterix is a medical device company that is pioneering
the use of robotics to improve minimally invasive surgery by
addressing the clinical and economic challenges associated with
current laparoscopic and robotic options. The company is focused on
the development and commercialization of the SurgiBot™ System, a
single-port, robotically enhanced laparoscopic surgical platform,
and the commercialization of ALF-X®, a multi-port robotic system
that brings the advantages of robotic surgery to patients while
enabling surgeons with innovative technology such as haptic
feedback and eye tracking camera control. The SurgiBot System is
not yet available for sale in any market. The ALF-X has been
granted a CE Mark but is not available for sale in the US. For more
information, visit the TransEnterix website
at www.transenterix.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151230005042/en/
For TransEnterix, Inc.Investor Contact:Mark Klausner,
443-213-0501transenterix@westwicke.comorMedia Contact:Joanna
Rice, 951-751-1858joanna@greymattermarketing.com
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Jul 2024 a Ago 2024
TransEnterix (AMEX:TRXC)
Gráfica de Acción Histórica
De Ago 2023 a Ago 2024
Real-Time news about TransEnterix Inc New (American Stock Exchange): 0 recent articles
Más de Transenterix, Inc. Artículos de Noticias